Literature DB >> 23872727

Management of acquired cholesteatoma in the pediatric population.

John L Dornhoffer1, Adva B Friedman, Michael B Gluth.   

Abstract

PURPOSE OF REVIEW: This review focuses on the most recent literature pertaining to pediatric acquired cholesteatoma and aims to integrate findings into a comprehensive management approach. RECENT
FINDINGS: Pediatric acquired cholesteatoma has been shown to differ from the adult variety secondary to anatomy and physiologic factors. Whereas the goals of therapeutic management are ultimately similar in adult and pediatric patients, special considerations must be taken into account when deciding on a treatment plan for a child. Although avoidance of an unstable mastoid cavity is an important consideration in this population, successful management has been reported with canal wall-up, canal wall-down, and hybrid techniques. Second-look procedures are also important when concern of recurrence exists. Newer innovations include endoscopic ear surgery and diffusion-weighted imaging.
SUMMARY: The principal goal of pediatric cholesteatoma management is eradication of disease. An individualized approach is paramount in yielding superior results in these patients. Special consideration should be given to anatomical and social factors.

Entities:  

Mesh:

Year:  2013        PMID: 23872727     DOI: 10.1097/MOO.0b013e32836464bd

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  Non-echoplanar diffusion-weighted MRI in children and adolescents with cholesteatoma: reliability and pitfalls in comparison to middle ear surgery.

Authors:  Thekla von Kalle; Peter Amrhein; Assen Koitschev
Journal:  Pediatr Radiol       Date:  2015-02-13

2.  Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.

Authors:  Victor J Kroon; Steven W Mes; Pepijn A Borggreven; Rick van de Langenberg; David R Colnot; Jasper J Quak
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

3.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

Review 4.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

5.  Cholesteatoma Versus Granulations: Changing Incidence Trends and Association with Age and Complications.

Authors:  Bharti Solanki; Shivam Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-11-23

6.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

Review 7.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

8.  Cholesteatoma in the Sellar Region Presenting as Hypopituitarism and Diabetes Insipidus.

Authors:  Xiangyi Kong; Huanwen Wu; Wenbin Ma; Yongning Li; Bing Xing; Yanguo Kong; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.